Search

Search Constraints

You searched for: Author/Creator Yokota, Tomoya

Search Results

1. A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141. (October 2017)

2. Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy. (20th June 2019)

3. Defining the needs of patients with recurrent and/or metastatic head and neck cancer: An expert opinion. (January 2021)

4. Human papillomavirus-related oropharyngeal carcinoma. (5th April 2022)

5. Immunotherapy for squamous cell carcinoma of the head and neck. (8th August 2020)

6. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck. (9th December 2020)

8. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Issue 10212 (23rd November 2019)

10. PS02.162: THREE-YEAR OVERALL SURVIVAL UPDATE FROM PHASE II STUDY OF CHEMOSELECTION WITH DCF AND SUBSEQUENT CONVERSION SURGERY FOR LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL CANCER. (14th September 2018)